VANGUARD GROUP INC - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 144 filers reported holding THERAPEUTICSMD INC in Q3 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q1 2022$6,631,000
-7.3%
17,448,224
-13.3%
0.00%
Q4 2021$7,156,000
-49.0%
20,129,380
+6.4%
0.00%
Q3 2021$14,021,000
-36.7%
18,910,787
+1.6%
0.00%
-100.0%
Q2 2021$22,148,000
-8.6%
18,611,213
+2.9%
0.00%0.0%
Q1 2021$24,243,000
+52.2%
18,091,349
+37.4%
0.00%
Q4 2020$15,931,000
-21.1%
13,165,644
+3.1%
0.00%
-100.0%
Q3 2020$20,180,000
+28.4%
12,772,708
+1.6%
0.00%0.0%
Q2 2020$15,711,000
-12.8%
12,569,339
-26.0%
0.00%0.0%
Q1 2020$18,008,000
-55.2%
16,989,962
+2.4%
0.00%0.0%
Q4 2019$40,159,000
-24.3%
16,595,225
+13.5%
0.00%
-50.0%
Q3 2019$53,069,000
+40.2%
14,619,657
+0.4%
0.00%
+100.0%
Q2 2019$37,862,000
-43.6%
14,562,689
+5.7%
0.00%
-66.7%
Q1 2019$67,081,000
+32.4%
13,774,222
+3.6%
0.00%
+50.0%
Q4 2018$50,655,000
-40.1%
13,295,496
+3.1%
0.00%
-33.3%
Q3 2018$84,585,000
+15.5%
12,894,027
+9.8%
0.00%0.0%
Q2 2018$73,260,000
+32.0%
11,740,311
+3.0%
0.00%
+50.0%
Q1 2018$55,491,000
-19.4%
11,394,241
-0.1%
0.00%
-33.3%
Q4 2017$68,879,000
+19.3%
11,403,826
+4.5%
0.00%0.0%
Q3 2017$57,714,000
+7.0%
10,910,125
+6.6%
0.00%0.0%
Q2 2017$53,918,000
-23.6%
10,231,081
+4.4%
0.00%
-25.0%
Q1 2017$70,574,000
+31.7%
9,801,870
+5.6%
0.00%
+33.3%
Q4 2016$53,580,000
-13.3%
9,285,878
+2.4%
0.00%
-25.0%
Q3 2016$61,776,000
-16.9%
9,071,417
+3.7%
0.00%
-20.0%
Q2 2016$74,377,000
+101.9%
8,750,158
+52.0%
0.01%
+150.0%
Q1 2016$36,837,000
-30.1%
5,755,789
+13.3%
0.00%
-50.0%
Q4 2015$52,670,000
+87.8%
5,079,041
+6.1%
0.00%
+300.0%
Q3 2015$28,039,000
-10.5%
4,784,928
+20.1%
0.00%
-50.0%
Q2 2015$31,320,000
+35.9%
3,984,778
+4.6%
0.00%0.0%
Q1 2015$23,039,000
+54.4%
3,808,146
+13.6%
0.00%
+100.0%
Q4 2014$14,918,000
+4.0%
3,352,353
+8.4%
0.00%0.0%
Q3 2014$14,350,000
+15.4%
3,092,752
+9.9%
0.00%0.0%
Q2 2014$12,437,000
-25.9%
2,813,966
+5.8%
0.00%0.0%
Q1 2014$16,780,000
+60.0%
2,659,221
+32.1%
0.00%0.0%
Q4 2013$10,490,000
+217.5%
2,013,464
+78.5%
0.00%
Q3 2013$3,304,000
+4.0%
1,127,748
+7.6%
0.00%
Q2 2013$3,176,0001,048,3880.00%
Other shareholders
THERAPEUTICSMD INC shareholders Q3 2020
NameSharesValueWeighting ↓
Rubric Capital Management LP 5,344,302$2,031,0000.07%
Asset Management Group, Inc. 735,040$279,0000.06%
SANDERS MORRIS HARRIS LLC 512,633$194,0000.04%
State of Wyoming 165,187$63,0000.03%
C WorldWide Group Holding A/S 6,189,834$2,352,0000.03%
PURA VIDA INVESTMENTS, LLC 1,619,080$615,0000.02%
Traynor Capital Management, Inc. 367,991$139,0000.02%
EMFO, LLC 44,500$17,0000.02%
Platform Technology Partners 70,000$27,0000.01%
Kowal Investment Group, LLC 99,357$38,0000.01%
View complete list of THERAPEUTICSMD INC shareholders